Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
MRI-based approach could provide a new way to detect and monitor fatty liver disease

MRI-based approach could provide a new way to detect and monitor fatty liver disease

Two less-studied forever chemicals linked to liver cancer risk

Two less-studied forever chemicals linked to liver cancer risk

FGF19-FGFR4 pathway has dual roles in liver health and cancer

FGF19-FGFR4 pathway has dual roles in liver health and cancer

Experimental vaccines aim to treat and prevent aggressive cancers

Experimental vaccines aim to treat and prevent aggressive cancers

EU-funded project develops mRNA vaccine targeting liver cancer

EU-funded project develops mRNA vaccine targeting liver cancer

Liver transplants dramatically extend survival for alcohol-associated liver disease

Liver transplants dramatically extend survival for alcohol-associated liver disease

Major studies identify accurate non-invasive tests for liver disease

Major studies identify accurate non-invasive tests for liver disease

Study identifies common mechanism behind widespread cancer mutations

Study identifies common mechanism behind widespread cancer mutations

New research center aims to accelerate hepatitis C vaccine development

New research center aims to accelerate hepatitis C vaccine development

Researchers harness cancer cells' carbon monoxide to produce anticancer drug

Researchers harness cancer cells' carbon monoxide to produce anticancer drug

AGA/AASLD joint guideline evaluates newer medications for primary biliary cholangitis

AGA/AASLD joint guideline evaluates newer medications for primary biliary cholangitis

Study identifies new genetic factors underlying fat accumulation in the liver

Study identifies new genetic factors underlying fat accumulation in the liver

Routine liver cancer screening extends lives for patients with alcohol-associated cirrhosis

Routine liver cancer screening extends lives for patients with alcohol-associated cirrhosis

New study identifies protein factor linked to chronic liver disease

New study identifies protein factor linked to chronic liver disease

SPRED2 coordinates three signaling pathways to suppress liver cancer stemness

SPRED2 coordinates three signaling pathways to suppress liver cancer stemness

Blood test detects more cancers when added to standard screening

Blood test detects more cancers when added to standard screening

Celastrol reduces cholestatic liver injury by inhibiting specific protein

Celastrol reduces cholestatic liver injury by inhibiting specific protein

Study defines early-onset cirrhosis caused by fatty liver disease

Study defines early-onset cirrhosis caused by fatty liver disease

Childhood chemotherapy leaves lasting DNA damage in healthy cells

Childhood chemotherapy leaves lasting DNA damage in healthy cells

Study reveals hidden DNA damage from childhood chemotherapy

Study reveals hidden DNA damage from childhood chemotherapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.